Williamson Steven S.
Williamson Steven S.'s purchase track record
Williamson Steven S. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/20/2024 | LUNG | $97K | -13.7% | +0.6% | +9.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Hims & Hers news mentioned in broader market context. Recent coverage from Yahoo discusses reasons to retain Hims & Hers stock, which shares the digital health sector with Outset Medical. While the article focuses on a different company, it highlights ongoing investor interest in the broader telehealth and digital medicine space. Outset Medical remains a high-beta stock with significant volatility, as seen in its wide 52-week range.
Transaction History
| LUNG | ▼ Sell | Open Market | 5,118 | $8K | 9/2/2025 | View on chart |
| LUNG | ▼ Sell | Open Market | 4,530 | $7K | 9/2/2025 | View on chart |
| LUNG | ▼ Sell | Open Market | 5,262 | $16K | 6/2/2025 | View on chart |
| LUNG | ▼ Sell | Open Market | 4,661 | $15K | 6/2/2025 | View on chart |
| LUNG | ▼ Sell | Open Market | 27,689 | $198K | 3/3/2025 | View on chart |
| LUNG | ▲ Buy | Grant | 181,696 | $0 | 3/3/2025 | View on chart |
| LUNG | ▲ Buy | Open Market | 14,245 | $97K | 8/20/2024 | View on chart |
| LUNG | ▲ Buy | Grant | 205,286 | $0 | 3/15/2024 | View on chart |
| OM | ▼ Sell | Open Market | 2,500 | $9K | 2/15/2024 | View on chart |
| OM | ▼ Sell | Open Market | 996 | $4K | 1/16/2024 | View on chart |
| OM | ▲ Buy | Grant | 112,000 | $0 | 1/12/2024 | View on chart |
| OM | ▲ Buy | Grant | 100,000 | $0 | 1/12/2024 | View on chart |
| OM | ▲ Buy | Grant | 5,904 | $0 | 1/12/2024 | View on chart |
| OM | ▼ Sell | Open Market | 7,055 | $39K | 1/8/2024 | View on chart |
| OM | ▼ Sell | Open Market | 3,584 | $17K | 11/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 635 | $10K | 8/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 681 | $14K | 5/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 10,000 | $198K | 5/8/2023 | View on chart |
| OM | ▼ Sell | Open Market | 694 | $17K | 2/16/2023 | View on chart |
| OM | ▼ Sell | Open Market | 3,023 | $84K | 1/27/2023 | View on chart |
| OM | ▲ Buy | Grant | 64,724 | $0 | 1/6/2023 | View on chart |
| OM | ▲ Buy | Grant | 3,641 | $0 | 1/6/2023 | View on chart |
| OM | ▼ Sell | Open Market | 3,422 | $66K | 11/16/2022 | View on chart |
| OM | ▲ Buy | Grant | 27,350 | $0 | 1/26/2022 | View on chart |
| OM | ▲ Buy | Grant | 1,538 | $0 | 1/26/2022 | View on chart |
| OM | ▼ Sell | Open Market | 2,280 | $86K | 1/25/2022 | View on chart |
| OM | ▲ Buy | Grant | 9,205 | $0 | 1/21/2022 | View on chart |
| OM | ▼ Sell | Open Market | 2,467 | $128K | 11/16/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Pulmonx Sets Q3 2026 Earnings Date for October 27
Pulmonx Corporation has announced that it will report its third-quarter 2026 financial results on October 27, 2026. This scheduled update provides a specific timeline for investors to review the company's latest performance metrics. The announcement serves as a standard corporate disclosure rather than a change in business operations.
Pulmonx Sets Q3 2026 Earnings Date for October 27. Pulmonx Corporation has announced that it will report its third-quarter 2026 financial results on October 27, 2026. This scheduled update provides a specific timeline for investors to review the company's latest performance metrics. The announcement serves as a standard corporate disclosure rather than a change in business operations.